PLIANT THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $-71.5M | $60.9M |
| Mar 2019 | — | $-86.5M | — |
| Jun 2019 | — | $-102.7M | $12.9M |
| Sep 2019 | — | $-116.9M | $11.4M |
| Dec 2019 | — | $-76.3M | $85.8M |
| Mar 2020 | — | $-64.8M | $113.4M |
| Jun 2020 | — | $315.8M | $178.5M |
| Sep 2020 | — | $300.3M | $55.2M |
| Dec 2020 | — | $283.1M | $50.9M |
| Mar 2021 | — | $264.2M | $50.8M |
| Jun 2021 | — | $244.0M | $35.2M |
| Sep 2021 | — | $220.4M | $45.2M |
| Dec 2021 | $0 | $199.1M | $51.7M |
| Mar 2022 | — | $173.8M | $32.5M |
| Jun 2022 | $9.9M | $147.8M | $25.1M |
| Sep 2022 | $9.9M | $337.0M | $44.6M |
| Dec 2022 | $9.9M | $313.3M | $33.7M |
| Mar 2023 | $10.0M | $561.9M | $102.5M |
| Jun 2023 | $10.0M | $533.1M | $55.0M |
| Sep 2023 | $10.0M | $503.0M | $57.7M |
| Dec 2023 | $10.1M | $473.6M | $63.2M |
| Mar 2024 | $30.0M | $437.3M | $114.3M |
| Jun 2024 | $30.1M | $392.7M | $80.4M |
| Sep 2024 | $30.1M | $345.8M | $79.6M |
| Dec 2024 | $30.2M | $304.1M | $71.2M |
| Mar 2025 | $30.3M | $257.2M | $91.9M |
| Jun 2025 | $30.4M | $220.1M | $86.8M |
| Sep 2025 | $30.4M | $200.3M | $93.7M |
| Dec 2025 | $0 | $181.2M | $45.4M |
| Mar 2026 | $0 | $165.2M | $22.2M |
| Jun 2026 | $0 | $146.9M | $24.9M |